Neuroscience Research on Drug Abuse (R03)

The summary for the Neuroscience Research on Drug Abuse (R03) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Neuroscience Research on Drug Abuse (R03): Purpose. This FOA issued by the National Institute on Drug Abuse (NIDA), National Institutes of Health, encourages research grant R03 applications from institutions/ organizations that are relevant to the understanding of the process(es) and mechanisms underlying drug abuse and addiction. The R03 grant mechanism supports different types of projects including pilot and feasibility studies; secondary analysis of existing data; small, self-contained research projects; development of research methodology; and development of new research technology.The R03 is intended to support small research projects that can be carried out in a short period of time with limited resources.Preliminary data are not required for an R03. Mechanism of Support. This FOA will utilize the NIH Small Research Grant (R03) award mechanism and runs in parallel with FOAs of identical scientific scope, PA-10-269, that encourages applications under the R21 mechanism, and PA-10-268 that encourages applications under the R01 mechanism. Funds Available and Anticipated Number of Awards. Because the R03 is a small grant mechanism, it is anticipated that the nature and scope of the proposed research will be limited. The number of awards will depend upon the quality and alignment with NIDAs programmatic priorities of the applications received. Budget and Project Period.Budgets for direct costs of up to $50,000 per year and a project duration of up to two years may be requested for a maximum of $100,000 direct costs over a two-year project period.
Federal Grant Title: Neuroscience Research on Drug Abuse (R03)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-10-270
Type of Funding: Grant
CFDA Numbers: 93.279
CFDA Descriptions: Drug Abuse and Addiction Research Programs
Current Application Deadline: Sep 07, 2013
Original Application Deadline: Sep 07, 2013
Posted Date: Aug 20, 2010
Creation Date: Aug 20, 2010
Archive Date: Oct 08, 2013
Total Program Funding:
Maximum Federal Grant Award: $50,000
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)
The National Drug Abuse Treatment Clinical Trials Network (UG1 Clinical Trial Optional)
Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Phar...
Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Phar...
HEALing Communities Study: Developing and Testing an Integrated Approach to Address the Op...
NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards
Drug Abuse Aspects of Hiv/Aids and Other Infections
Epidemiology of Drug Abuse
More Grants from the National Institutes of Health
Implementation Science for Cancer Control: Developing Centers (P50 Clinical Trial Optional...
Medications Development for the Treatment of Alcohol Use Disorder (U01 Clinical Trial Opti...
Enabling Technologies to Accelerate Development of Oral Biodevices (R01 Clinical Trial Not...
Enabling Technologies to Accelerate Development of Oral Biodevices (R21 Clinical Trial Not...
Implementation Science for Cancer Control: Advanced Centers (P50 Clinical Trial Optional)

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com